SEPSIS YANG DISEBABKAN KUMAN MRSA PADA PASIEN POST COVID-19

Elsa Purnama Sari, Irvan Medison, Russilawati Russilawati

Abstract


Sepsis adalah adanya respon sistemik terhadap infeksi di dalam tubuh yang dapat berkembang menjadi sepsis berat dan syok septik. Sepsis dapat disebabkan berbagai jenis kuman, salah satunya yang menjadi masalah kesehatan global utama adalah kuman Staphylococcus aureus resisten obat atau Multidrug Resistant Staphylococcus Aureus (MRSA). Laporan kasus ini membahas tentang seorang pasien yang telah sembuh dari COVID-19 (post COVID-19) kemudian mengalami sepsis yang disebabkan MRSA berdasarkan hasil pemeriksaan kultur darah. Pasien telah diberikan tatalaksana sesuai protokol sepsis serta terapi antibiotik berdasarkan hasil kultur dan pola sensitivitas kuman yaitu vankomisin dan amikacin. Kondisi pasien makin memburuk dengan mengalami syok sepsis dan akhirnya meninggal dunia setelah 22 hari dirawat di RS dr. M. Djamil Padang. 


Keywords


sepsis, MRSA, post COVID-19

References


Mehta Y, Kochhar G. Sepsis and septic shock. J Card Crit Care. 2017;1(August):3–5.

Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol. 43, Intensive Care Medicine. Springer Berlin Heidelberg; 2017. 304–77 p.

Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus Infections?: Epidemiology , Pathophysiology , Clinical Manifestations , and Management. 2015;28(3):603–61.

Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care. 2017;21(1):211–4.

Vigil DI, Harden WD, Hines AE, Hosokawa PW, Henderson WG, Bessesen MT. Risk of MRSA infection in patients with intermittent versus persistent MRSA Nares colonization. Infect Control Hosp Epidemiol. 2015;36(11):1292–7.

Lam SW, Bauer SR, Neuner EA. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia. Int J Infect Dis. 2012;16(6):453–6.

Algammal AM, Hetta HF, Elkelish A, Alkhalifah DHH, Hozzein WN, Batiha GES, et al. Methicillin-resistant staphylococcus aureus (MRSA): One health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infect Drug Resist. 2020;13:3255–65.

Algammal AM, El-Sayed ME, Youssef FM, Saad SA, Elhaig MM, Batiha GE, et al. Prevalence, the antibiogram and the frequency of virulence genes of the most predominant bacterial pathogens incriminated in calf pneumonia. AMB Express. 2020;10(1):1–7.

Prenafeta A, Sitjà M, Holmes MA, Paterson GK. Short communication: Biofilm production characterization of mecA and mecC methicillin-resistant Staphylococcus aureus isolated from bovine milk in Great Britain. J Dairy Sci. 2014;97(8):4838–41.

Gajdács M. The concept of an ideal antibiotic: Implications for drug design. Molecules. 2019;24(5):1–5.

Irvan I, Febyan F, Suparto S. Sepsis dan Tata Laksana Berdasar Guideline Terbaru. JAI (Jurnal Anestesiol Indones. 2018;10(1):62–4.

Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A, et al. Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? Ann Intensive Care. 2017;7(1):1–18.

De Backer D, Dorman T. A Continuous Move Toward Better Care of Patients With Sepsis. JAMA - J Am Med Assoc. 2017;317(8):807–8.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol. 45, Critical Care Medicine. 2017. 486–552 p.

Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, et al. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clin Ther. 2016;38(1):16–30.

Al-Jahdhami I, Al-Naamani K, Al-Mawali A. The post-acute COVID-19 syndrome (Long COVID). Oman Med J. 2021;36(1):1–2.

Nalbandian A, Sehgal K, Gupta A, Madhavan M V., McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15.




DOI: https://doi.org/10.32502/sm.v13i1.4478

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Elsa Purnama Sari

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

   

Statistic counter 

sinta4